GenomeDx Biosciences $25 Million Development of Prostate Cancer Genome Detection Kit
Release date: 2016-03-16
March 15, 2016 As medical standards improve, people have recognized the importance of updating test methods for disease treatment. Therefore, many biopharmaceutical companies that focus on the development of new detection methods are increasingly sought after by the industry. Recently, GenomeDx Biosciences announced that it will raise more than $25 million to promote the promotion of the latest prostate cancer genome test method Decipher Biopsy. The San Diego-based biotechnology company has been working on genomics analysis of prostate cancer. The company has brought Decipher Biopsy to market last month.
Decipher Biopsy is based on the company's urology tumor genome database technology Decipher Grid. This technology has been recognized as the largest clinical genomic database in the field. Decipher Biopsy can be based on biomarkers of RNA expression in urine to predict the risk of a subject developing the disease.
A recent study conducted at the Cleveland Clinic showed that Decipher Biopsy combined with traditional clinical testing methods is expected to show extremely high accuracy for prostate cancer patients. In addition, the researchers believe that the disease risk stratification established by this method can help doctors and patients to better develop treatment measures.
Prostate cancer is one of the major cancer types that threaten men's health. Some people expect that 200,000 men in the United States will develop this cancer every year. Decipher Biopsy can help doctors better determine the risk of these patients and help them.
The latest financing activity of GenomeDx Biosciences can be traced back to the 2013 B round of financing. Many well-known venture capital companies, including the Merck's Global Health Innovation Fund, are involved. In this round of financing, well-known companies such as Tekla Capital, Baird Capital Management, and Capital AG are also involved.
Source: Bio Valley
Creport3000 Series Medical Pendant equipment used in modern clean operation rooms and general operation rooms. It is an ideal and practical endoscopic workstation . This pendent is a practical equipment used in modern clean operation rooms and general operation rooms . All kinds of terminals such as for medical gas , electricity , network are all gathered on the control board.
nesthesia Pendant,Ceiling Pendant,Hospital Pendant,Medical Gas Pendant
Shandong Lewin Medical Equipment Co., Ltd. , https://www.lewinmed.com